Bioengineered mesenchymal stem cell-derived exosomes: emerging strategies for diabetic wound healing

Abstract

Diabetic wounds are among the most common complications of diabetes mellitus and their healing process can be delayed due to persistent inflammatory reactions, bacterial infections, damaged vascularization and impaired cell proliferation, which casts a blight on patients’ health and quality of life. Therefore, new strategies to accelerate diabetic wound healing are being positively explored. Exosomes derived from mesenchymal stem cells (MSC-Exos) can inherit the therapeutic and reparative abilities of stem cells and play a crucial role in diabetic wound healing. However, poor targeting, low concentrations of therapeutic molecules, easy removal from wounds and limited yield of MSC-Exos are challenging for clinical applications. Bioengineering techniques have recently gained attention for their ability to enhance the efficacy and yield of MSC-Exos. In this review, we summarise the role of MSC-Exos in diabetic wound healing and focus on three bioengineering strategies, namely, parental MSC-Exos engineering, direct MSC-Exos engineering and MSC-Exos combined with biomaterials. Furthermore, the application of bioengineered MSC-Exos in diabetic wound healing is reviewed. Finally, we discuss the future prospects of bioengineered MSC-Exos, providing new insights into the exploration of therapeutic strategies.

Keywords

Mesenchymal stem cells / Exosomes / Diabetic wound healing / Bioengineering strategies / Application / Biomaterial

References

[1] Thewjitcharoen Y, Sripatpong J, Krittiyawong S, Porramatikul S, Srikummoon T, Mahaudomporn S, et al. Changing the patterns of hospitalized diabetic foot ulcer (DFU) over a 5-year period in a multi-disciplinary setting in Thailand. BMC Endocr Disord. 2020; 20: 89.

[2] Armstrong DG, Swerdlow MA, Armstrong AA, Conte MS, Padula WV, Bus SA. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. J Foot Ankle Res. 2020; 13: 16.

[3] Patel S, Srivastava S, Singh MR, Singh D. Mechanistic insight into diabetic wounds: pathogenesis, molecular targets and treatment strategies to pace wound healing. Biomed Pharmacother. 2019; 112: 108615.

[4] An T, Chen Y, Tu Y, Lin P. Mesenchymal stromal cell-derived extracellular vesicles in the treatment of diabetic foot ulcers: application and challenges. Stem Cell Rev Rep. 2021; 17: 369-78.

[5] Jing S, Li H, Xu H. Mesenchymal stem cell derived exosomes therapy in diabetic wound repair. Int J Nanomedicine. 2023;Volume 18: 2707-20.

[6] Riau AK, Ong HS, Yam GHF, Mehta JS. Sustained delivery system for stem cell-derived exosomes. Front Pharmacol. 2019; 10: 1368.

[7] Tian Y, Li S, Song J, Ji T, Zhu M, Anderson GJ, et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials. 2014; 35: 2383-90.

[8] Riazifar M, Pone EJ, Lötvall J, Zhao W. Stem cell extracellular vesicles: extended messages of regeneration. Annu Rev Pharmacol Toxicol. 2017; 57: 125-54.

[9] Broughton G, 2nd, Janis JE, Attinger CE. Wound healing: an overview. Plast Reconstr Surg. 2006; 117: 1e-32e-S.

[10] Beke Debreceni I, Mezei G, Batár P, Illés Á, Kappelmayer J. Dasatinib inhibits Procoagulant and clot retracting activities of human platelets. Int J Mol Sci. 2019; 20. https://doi.org/10.3390/ijms20215430.

[11] Wada Y, Suzuki A, Ishiguro H, Murakashi E, Numabe Y. Chronological gene expression of human gingival fibroblasts with low reactive level laser (LLL) irradiation. J Clin Med. 2021; 10. https://doi.org/10.3390/jcm10091952.

[12] Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res. 2010; 89: 219-29.

[13] Rajendran NK, Dhilip Kumar SS, Houreld NN, Abrahamse H. Understanding the perspectives of forkhead transcription factors in delayed wound healing. J Cell Commun Signal. 2019; 13: 151-62.

[14] Liu W, Yu M, Xie D, Wang L, Ye C, Zhu Q, et al. Melatonin-stimulated MSC-derived exosomes improve diabetic wound healing through regulating macrophage M1 and M2 polarization by targeting the PTEN/AKT pathway. Stem Cell Res Ther. 2020; 11: 259.

[15] Hsieh CC, Wang CH. Aspirin disrupts the crosstalk of Angiogenic and inflammatory cytokines between 4T1 breast cancer cells and macrophages. Mediat Inflamm. 2018; 2018: 6380643-12.

[16] Shabestani Monfared G, Ertl P, Rothbauer M. An on-chip wound healing assay fabricated by xurography for evaluation of dermal fibroblast cell migration and wound closure. Sci Rep. 2020; 10: 16192.

[17] Soib HH, Ismail HF, Husin F, Abu Bakar MH, Yaakob H, Sarmidi MR. Bioassay-guided different extraction techniques of Carica papaya (Linn.) leaves on In vitro wound-healing activities. Molecules. 2020; 25. https://doi.org/10.3390/molecules25030517.

[18] Tsalamandris S, Antonopoulos AS, Oikonomou E, Papamikroulis GA, Vogiatzi G, Papaioannou S, et al. The role of inflammation in diabetes: current concepts and future perspectives. Eur Cardiol. 2019; 14: 50-9.

[19] Wolf SJ, Melvin WJ, Gallagher K. Macrophage-mediated inflammation in diabetic wound repair. Semin Cell Dev Biol. 2021; 119: 111-8.

[20] Yan J, Tie G, Wang S, Tutto A, DeMarco N, Khair L, et al. Diabetes impairs wound healing by Dnmt1-dependent dysregulation of hematopoietic stem cells differentiation towards macrophages. Nat Commun. 2018; 9: 33.

[21] Fui LW, Lok MPW, Govindasamy V, Yong TK, Lek TK, Das AK. Understanding the multifaceted mechanisms of diabetic wound healing and therapeutic application of stem cells conditioned medium in the healing process. J Tissue Eng Regen Med. 2019; 13: 2218-33.

[22] Davis FM, Kimball A, Boniakowski A, Gallagher K. Dysfunctional wound healing in diabetic foot ulcers: new crossroads. Curr Diab Rep. 2018; 18: 2.

[23] Lan CC, Wu CS, Huang SM, Wu IH, Chen GS. High-glucose environment enhanced oxidative stress and increased interleukin-8 secretion from keratinocytes: new insights into impaired diabetic wound healing. Diabetes. 2013; 62: 2530-8.

[24] Loot MA, Kenter SB, Au FL, van Galen WJ, Middelkoop E, Bos JD, et al. Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls. Eur J Cell Biol. 2002; 81: 153-60.

[25] Zhang J, Yang P, Liu D, Gao M, Wang J, Wang X, et al. c-Myc upregulated by high glucose inhibits HaCaT differentiation by S100A6 transcriptional activation. Front Endocrinol (Lausanne). 2021; 12: 676403.

[26] Wan R, Weissman JP, Grundman K, Lang L, Grybowski DJ, Galiano RD. Diabetic wound healing: the impact of diabetes on myofibroblast activity and its potential therapeutic treatments. Wound Repair Regen. 2021; 29: 573-81.

[27] Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat Rev Endocrinol. 2021; 17: 400-20.

[28] Aitcheson SM, Frentiu FD, Hurn SE, Edwards K, Murray RZ. Skin wound healing: normal macrophage function and macrophage dysfunction in diabetic wounds. Molecules. 2021; 26. https://doi.org/10.3390/molecules26164917.

[29] Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem. 2019; 88: 487-514.

[30] Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020; 367. https://doi.org/10.1126/science.aau6977.

[31] Mashouri L, Yousefi H, Aref AR, Ahadi AM, Molaei F, Alahari SK. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer. 2019; 18: 75.

[32] Han QF, Li WJ, Hu KS, Gao J, Zhai WL, Yang JH, et al. Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer. Mol Cancer. 2022; 21: 207.

[33] Keller S, Sanderson MP, Stoeck A, Altevogt P. Exosomes: from biogenesis and secretion to biological function. Immunol Lett. 2006; 107: 102-8.

[34] Isaac R, Reis FCG, Ying W, Olefsky JM. Exosomes as mediators of intercellular crosstalk in metabolism. Cell Metab. 2021; 33: 1744-62.

[35] Wang J, Wu H, Peng Y, Zhao Y, Qin Y, Zhang Y, et al. Hypoxia adipose stem cell-derived exosomes promote high-quality healing of diabetic wound involves activation of PI3K/Akt pathways. J Nanobiotechnology. 2021; 19: 202.

[36] Chen R, Xu X, Tao Y, Qian Z, Yu Y. Exosomes in hepatocellular carcinoma: a new horizon. Cell Commun Signal. 2019; 17: 1.

[37] Gurung S, Perocheau D, Touramanidou L, Baruteau J. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal. 2021; 19: 47.

[38] Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. D-0404511, (-1095-9203 (Electronic)):T-ppublish.

[39] Päth G, Perakakis N, Mantzoros CS, Seufert J. Stem cells in the treatment of diabetes mellitus-focus on mesenchymal stem cells. Metabolism. 2019; 90: 1-15.

[40] Krasilnikova OA, Baranovskii DS, Lyundup AV, Shegay PV, Kaprin AD, Klabukov ID. Stem and somatic cell monotherapy for the treatment of diabetic foot ulcers: review of clinical studies and mechanisms of action. Stem Cell Rev Rep. 2022; 18: 1974-85.

[41] Galipeau J, Sensébé L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell. 2018; 22: 824-33.

[42] Wu J, Chen LH, Sun SY, Li Y, Ran XW. Mesenchymal stem cell-derived exosomes: the dawn of diabetic wound healing. World J Diabetes. 2022; 13: 1066-95.

[43] Liang ZH, Lin SS, Pan NF, Zhong GY, Qiu ZY, Kuang SJ, et al. UCMSCs-derived exosomal circHIPK3 promotes ulcer wound angiogenesis of diabetes mellitus via miR-20b-5p/Nrf2/VEGFA axis. Diabet Med. 2023; 40: e14968.

[44] Hsu HH, Wang AYL, Loh CYY, Pai AA, Kao HK. Therapeutic potential of exosomes derived from diabetic adipose stem cells in cutaneous wound healing of db/db mice. Pharmaceutics. 2022; 14. https://doi.org/10.3390/pharmaceutics14061206.

[45] Li J, Li Z, Wang S, Bi J, Huo R. Exosomes from human adipose-derived mesenchymal stem cells inhibit production of extracellular matrix in keloid fibroblasts via downregulating transforming growth factor-β2 and Notch-1 expression. Bioengineered. 2022; 13: 8515-25.

[46] He L, Zhu C, Jia J, Hao XY, Yu XY, Liu XY, et al. ADSC-exos containing MALAT1 promotes wound healing by targeting miR-124 through activating Wnt/β-catenin pathway. Biosci Rep. 2020; 40. https://doi.org/10.1042/bsr20192549.

[47] Liu Y, Liu Y, Zhang M, Li C, Zhang Z, Liu A, et al. Structural characterization of a polysaccharide from Suillellus luridus and its antidiabetic activity via Nrf2/HO-1 and NF-κB pathways. Int J Biol Macromol. 2020; 162: 935-45.

[48] Shen K, Jia Y, Wang X, Zhang J, Liu K, Wang J, et al. Exosomes from adipose-derived stem cells alleviate the inflammation and oxidative stress via regulating Nrf2/HO-1 axis in macrophages. Free Radic Biol Med. 2021; 165: 54-66.

[49] Zhang Y, Bai X, Shen K, Luo L, Zhao M, Xu C, et al. Exosomes derived from adipose mesenchymal stem cells promote diabetic chronic wound healing through SIRT3/SOD2. Cells. 2022; 11. https://doi.org/10.3390/cells11162568.

[50] Chen J, Li X, Liu H, Zhong D, Yin K, Li Y, et al. Bone marrow stromal cell-derived exosomal circular RNA improves diabetic foot ulcer wound healing by activating the nuclear factor erythroid 2-related factor 2 pathway and inhibiting ferroptosis. Diabet Med. 2023; 40: e15031.

[51] Wei Q, Wang Y, Ma K, Li Q, Li B, Hu W, et al. Extracellular vesicles from human umbilical cord mesenchymal stem cells facilitate diabetic wound healing through MiR-17-5p-mediated enhancement of angiogenesis. Stem Cell Rev Rep. 2022; 18: 1025-40.

[52] Wei Q, Liu X, Su JL, Wang YX, Chu ZQ, Ma K, et al. Small extracellular vesicles from mesenchymal stem cells: a potential weapon for chronic non-healing wound treatment. Front Bioeng Biotechnol. 2022; 10: 1083459.

[53] Su J, Wei Q, Ma K, Wang Y, Hu W, Meng H, et al. P-MSC-derived extracellular vesicles facilitate diabetic wound healing via miR-145-5p/ CDKN1A-mediated functional improvements of high glucose-induced senescent fibroblasts. Burns. Trauma. 2023; 11: tkad010.

[54] Witwer KW, Van Balkom BWM, Bruno S, Choo A, Dominici M, Gimona M, et al. Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications. J Extracell Vesicles. 2019; 8: 1609206.

[55] Lv Q, Deng J, Chen Y, Wang Y, Liu B, Liu J. Engineered human adipose stem-cell-derived exosomes loaded with miR-21-5p to promote diabetic cutaneous wound healing. Mol Pharm. 2020; 17: 1723-33.

[56] Zhang J, Qu X, Li J, Harada A, Hua Y, Yoshida N, et al. Tissue sheet engineered using human umbilical cord-derived mesenchymal stem cells improves diabetic wound healing. Int J Mol Sci. 2022; 23. https://doi.org/10.3390/ijms232012697.

[57] Richter M, Vader P, Fuhrmann G. Approaches to surface engineering of extracellular vesicles. Adv Drug Deliv Rev. 2021; 173: 416-26.

[58] Curley N, Levy D, Do MA, Brown A, Stickney Z, Marriott G, et al. Sequential deletion of CD63 identifies topologically distinct scaffolds for surface engineering of exosomes in living human cells. Nanoscale. 2020; 12: 12014-26.

[59] Mentkowski KI, Snitzer JD, Rusnak S, Lang JK. Therapeutic potential of engineered extracellular vesicles. AAPS J. 2018; 20: 50.

[60] Chen K, Conti PS. Target-specific delivery of peptide-based probes for PET imaging. Adv Drug Deliv Rev. 2010; 62: 1005-22.

[61] Liang Y, Duan L, Lu J, Xia J. Engineering exosomes for targeted drug delivery. Theranostics. 2021; 11: 3183-95.

[62] Yang J, Zhang X, Chen X, Wang L, Yang G. Exosome mediated delivery of miR-124 promotes neurogenesis after ischemia. Mol Ther Nucleic Acids. 2017; 7: 278-87.

[63] Liang Y, Xu X, Li X, Xiong J, Li B, Duan L, et al. Chondrocyte-targeted MicroRNA delivery by engineered exosomes toward a cell-free osteoarthritis therapy. ACS Appl Mater Interfaces. 2020; 12: 36938-47.

[64] Shi A, Li J, Qiu X, Sabbah M, Boroumand S, Huang TC, et al. TGF-β loaded exosome enhances ischemic wound healing in vitro and in vivo. Theranostics. 2021; 11: 6616-31.

[65] Nakamura Y, Kita S, Tanaka Y, Fukuda S, Obata Y, Okita T, et al. Adiponectin stimulates exosome release to enhance mesenchymal stem-cell-driven therapy of heart failure in mice. Mol Ther. 2020; 28: 2203-19.

[66] Ohno S, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N, et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther. 2013; 21: 185-91.

[67] Tian T, Cao L, He C, Ye Q, Liang R, You W, et al. Targeted delivery of neural progenitor cell-derived extracellular vesicles for anti-inflammation after cerebral ischemia. Theranostics. 2021; 11: 6507-21.

[68] Narayanan R, Huang CC, Ravindran S. Hijacking the cellular mail: exosome mediated differentiation of mesenchymal stem cells. Stem Cells Int. 2016; 2016: 3808674-11.

[69] Li Q, Hu W, Huang Q, Yang J, Li B, Ma K, et al. MiR146a-loaded engineered exosomes released from silk fibroin patch promote diabetic wound healing by targeting IRAK1. Signal Transduct Target Ther. 2023; 8: 62.

[70] Yuan R, Dai X, Li Y, Li C, Liu L. Exosomes from miR-29a-modified adipose-derived mesenchymal stem cells reduce excessive scar formation by inhibiting TGF-β2/Smad3 signaling. Mol Med Rep. 2021; 24. https://doi.org/10.3892/mmr.2021.12398.

[71] Shao L, Zhang Y, Pan X, Liu B, Liang C, Zhang Y, et al. Knockout of beta-2 microglobulin enhances cardiac repair by modulating exosome imprinting and inhibiting stem cell-induced immune rejection. Cell Mol Life Sci. 2020; 77: 937-52.

[72] Golchin A, Shams F, Karami F. Advancing mesenchymal stem cell therapy with CRISPR/Cas9 for clinical trial studies. Adv Exp Med Biol. 2020; 1247: 89-100.

[73] Sosa-Acosta JR, Iriarte-Mesa C, Ortega GA, Díaz-García AM. DNA-iron oxide nanoparticles conjugates: functional magnetic Nanoplatforms in biomedical applications. Top Curr Chem (Cham). 2020; 378: 13.

[74] Li A, Zhang T, Huang T, Lin R, Mu J, Su Y, et al. Iron oxide nanoparticles promote Cx43-overexpression of mesenchymal stem cells for efficient suicide gene therapy during glioma treatment. Theranostics. 2021; 11: 8254-69.

[75] Wang T, Zhao H, Jing S, Fan Y, Sheng G, Ding Q, et al. Magnetofection of miR-21 promoted by electromagnetic field and iron oxide nanoparticles via the p38 MAPK pathway contributes to osteogenesis and angiogenesis for intervertebral fusion. J Nanobiotechnology. 2023; 21: 27.

[76] Abdelrahman SA, Samak MA, Shalaby SM. Fluoxetine pretreatment enhances neurogenic, angiogenic and immunomodulatory effects of MSCs on experimentally induced diabetic neuropathy. Cell Tissue Res. 2018; 374: 83-97.

[77] Liang B, Liang JM, Ding JN, Xu J, Xu JG, Chai YM. Dimethyloxaloylglycine-stimulated human bone marrow mesenchymal stem cell-derived exosomes enhance bone regeneration through angiogenesis by targeting the AKT/mTOR pathway. Stem Cell Res Ther. 2019; 10: 335.

[78] Ariyanti AD, Zhang J, Marcelina O, Nugrahaningrum DA, Wang G, Kasim V, et al. Salidroside-Pretreated mesenchymal stem cells enhance diabetic wound healing by promoting paracrine function and survival of mesenchymal stem cells under Hyperglycemia. Stem Cells Transl Med. 2019; 8: 404-14.

[79] Shi R, Jin Y, Zhao S, Yuan H, Shi J, Zhao H. Hypoxic ADSC-derived exosomes enhance wound healing in diabetic mice via delivery of circ-Snhg11 and induction of M2-like macrophage polarization. Biomed Pharmacother. 2022; 153: 113463.

[80] Shi H, Xu X, Zhang B, Xu J, Pan Z, Gong A, et al. 3,3’-Diindolylmethane stimulates exosomal Wnt11 autocrine signaling in human umbilical cord mesenchymal stem cells to enhance wound healing. Theranostics. 2017; 7: 1674-88.

[81] Heo JS. Selenium-stimulated exosomes enhance wound healing by modulating inflammation and angiogenesis. Int J Mol Sci. 2022; 23. https://doi.org/10.3390/ijms231911543.

[82] Jafari D, Malih S, Eini M, Jafari R, Gholipourmalekabadi M, Sadeghizadeh M, et al. Improvement, scaling-up, and downstream analysis of exosome production. Crit Rev Biotechnol. 2020; 40: 1098-112.

[83] Chen H, Wang L, Zeng X, Schwarz H, Nanda HS, Peng X, et al. Exosomes, a new star for targeted delivery. Front Cell Dev Biol. 2021; 9: 751079.

[84] Hahm J, Kim J, Park J. Strategies to enhance extracellular vesicle production. Tissue Eng Regen Med. 2021; 18: 513-24.

[85] Zipkin M. Exosome redux. Nat Biotechnol. 2019; 37: 1395-400.

[86] Yan L, Wu X. Exosomes produced from 3D cultures of umbilical cord mesenchymal stem cells in a hollow-fiber bioreactor show improved osteochondral regeneration activity. Cell Biol Toxicol. 2020; 36: 165-78.

[87] Petry F, Smith JR, Leber J, Salzig D, Czermak P, Weiss ML. Manufacturing of human umbilical cord mesenchymal stromal cells on microcarriers in a dynamic system for clinical use. Stem Cells Int. 2016; 2016: 4834616-2.

[88] Lee BC, Kang KS. Functional enhancement strategies for immunomodulation of mesenchymal stem cells and their therapeutic application. Stem Cell Res Ther. 2020; 11: 397.

[89] Wu Z, He D, Li H. Bioglass enhances the production of exosomes and improves their capability of promoting vascularization. Bioact Mater. 2021; 6: 823-35.

[90] Yang Z, Shi J, Xie J, Wang Y, Sun J, Liu T, et al. Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation. Nat Biomed Eng. 2020; 4: 69-83.

[91] You Y, Tian Y, Yang Z, Shi J, Kwak KJ, Tong Y, et al. Intradermally delivered mRNA-encapsulating extracellular vesicles for collagen-replacement therapy. Nat Biomed Eng. 2023; 7: 887-900.

[92] Butreddy A, Kommineni N, Dudhipala N. Exosomes as naturally occurring vehicles for delivery of biopharmaceuticals: insights from drug delivery to clinical perspectives. Nanomaterials (Basel). 2021; 11. https://doi.org/10.3390/nano11061481.

[93] Parada N, Romero-Trujillo A, Georges N, Alcayaga-Miranda F. Camouflage strategies for therapeutic exosomes evasion from phagocytosis. J Adv Res. 2021; 31: 61-74.

[94] Tian T, Zhang HX, He CP, Fan S, Zhu YL, Qi C, et al. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials. 2018; 150: 137-49.

[95] Lee TS, Kim Y, Zhang W, Song IH, Tung CH. Facile metabolic glycan labeling strategy for exosome tracking. Biochim Biophys Acta Gen Subj. 2018; 1862: 1091-100.

[96] Cui Y, Guo Y, Kong L, Shi J, Liu P, Li R, et al. A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis. Bioact Mater. 2022; 10: 207-21.

[97] Wen J, Chen Y, Liao C, Ma X, Wang M, Li Q, et al. Engineered mesenchymal stem cell exosomes loaded with miR-34c-5p selectively promote eradication of acute myeloid leukemia stem cells. Cancer Lett. 2023; 575: 216407.

[98] Guo S, Perets N, Betzer O, Ben-Shaul S, Sheinin A, Michaelevski I, et al. Intranasal delivery of mesenchymal stem cell derived exosomes loaded with phosphatase and Tensin homolog siRNA repairs complete spinal cord injury. ACS Nano. 2019; 13: 10015-28.

[99] Luan X, Sansanaphongpricha K, Myers I, Chen H, Yuan H, Sun D. Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin. 2017; 38: 754-63.

[100] Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011; 29: 341-5.

[101] Schulz-Siegmund M, Aigner A. Nucleic acid delivery with extracellular vesicles. Adv Drug Deliv Rev. 2021; 173: 89-111.

[102] Hajipour H, Farzadi L, Roshangar L, Latifi Z, Kahroba H, Shahnazi V, et al. A human chorionic gonadotropin (hCG) delivery platform using engineered uterine exosomes to improve endometrial receptivity. Life Sci. 2021; 275: 119351. https://doi.org/10.1016/j.lfs.2021.119351.

[103] Sun W, Li Z, Zhou X, Yang G, Yuan L. Efficient exosome delivery in refractory tissues assisted by ultrasound-targeted microbubble destruction. Drug Deliv. 2019; 26: 45-50.

[104] Khongkow M, Yata T, Boonrungsiman S, Ruktanonchai UR, Graham D, Namdee K. Surface modification of gold nanoparticles with neuron-targeted exosome for enhanced blood-brain barrier penetration. Sci Rep. 2019; 9: 8278.

[105] Van Deun J, Roux Q, Deville S, Van Acker T, Rappu P, Miinalainen I, et al. Feasibility of mechanical extrusion to coat nanoparticles with extracellular vesicle membranes. Cells. 2020; 9. https://doi.org/10.3390/cells9081797.

[106] Guo C, Wu Y, Li W, Wang Y, Kong Q. Development of a microenvironment-responsive hydrogel promoting chronically infected diabetic wound healing through sequential Hemostatic, antibacterial, and Angiogenic activities. ACS Appl Mater Interfaces. 2022; 14: 30480-92.

[107] Ahmed EM. Hydrogel: preparation, characterization, and applications: a review. J Adv Res. 2015; 6: 105-21.

[108] Henriques-Antunes H, Cardoso RMS, Zonari A, Correia J, Leal EC, Jiménez-Balsa A, et al. The kinetics of small extracellular vesicle delivery impacts skin tissue regeneration. ACS Nano. 2019; 13: 8694-707.

[109] Yang J, Chen Z, Pan D, Li H, Shen J. Umbilical cord-derived mesenchymal stem cell-derived exosomes combined Pluronic F127 hydrogel promote chronic diabetic wound healing and complete skin regeneration. Int J Nanomedicine. 2020; 15: 5911-26.

[110] Wu D, Tao S, Zhu L, Zhao C, Xu N. Chitosan hydrogel dressing loaded with adipose mesenchymal stem cell-derived exosomes promotes skin full-thickness wound repair. ACS Appl Bio Mater. 2024; 7: 1125-34.

[111] Shen K, Duan A, Cheng J, Yuan T, Zhou J, Song H, et al. Exosomes derived from hypoxia preconditioned mesenchymal stem cells laden in a silk hydrogel promote cartilage regeneration via the miR-205-5p/PTEN/AKT pathway. Acta Biomater. 2022; 143: 173-88.

[112] Kwak G, Cheng J, Kim H, Song S, Lee SJ, Yang Y, et al. Sustained exosome-guided macrophage polarization using hydrolytically degradable PEG hydrogels for cutaneous wound healing: identification of key proteins and MiRNAs, and sustained release formulation. Small. 2022; 18:e2200060.

[113] Zhang X, Gan J, Fan L, Luo Z, Zhao Y. Bioinspired adaptable indwelling microneedles for treatment of diabetic ulcers. Adv Mater. 2023; 35:e2210903.

[114] Ju Y, Hu Y, Yang P, Xie X, Fang B. Extracellular vesicle-loaded hydrogels for tissue repair and regeneration. Mater Today Bio. 2023; 18: 100522.

[115] Sánchez-Cid P, Jiménez-Rosado M, Romero A, Pérez-Puyana V. Novel trends in hydrogel development for biomedical applications: a review. Polymers (Basel). 2022; 14. https://doi.org/10.3390/polym14153023.

[116] Geng X, Qi Y, Liu X, Shi Y, Li H, Zhao L. A multifunctional antibacterial and self-healing hydrogel laden with bone marrow mesenchymal stem cell-derived exosomes for accelerating diabetic wound healing. Biomater Adv. 2022; 133: 112613.

[117] Pang L, Jin H, Lu Z, Xie F, Shen H, Li X, et al. Treatment with mesenchymal stem cell-derived Nanovesicle-containing Gelatin Methacryloyl hydrogels alleviates osteoarthritis by modulating Chondrogenesis and macrophage polarization. Adv Healthc Mater. 2023; 12: e2300315.

[118] Wang L, Wang J, Zhou X, Sun J, Zhu B, Duan C, et al. A new self-healing hydrogel containing hucMSC-derived exosomes promotes bone regeneration. Front Bioeng Biotechnol. 2020; 8: 564731.

[119] Jiang T, Liu S, Wu Z, Li Q, Ren S, Chen J, et al. ADSC-exo@MMP-PEG smart hydrogel promotes diabetic wound healing by optimizing cellular functions and relieving oxidative stress. Mater Today Bio. 2022; 16: 100365.

[120] Wang C, Wang M, Xu T, Zhang X, Lin C, Gao W, et al. Engineering bioactive self-healing antibacterial exosomes hydrogel for promoting chronic diabetic wound healing and complete skin regeneration. Theranostics. 2019; 9: 65-76.

[121] Born LJ, Chang KH, Shoureshi P, Lay F, Bengali S, Hsu ATW, et al. HOTAIR-loaded mesenchymal stem/stromal cell extracellular vesicles enhance angiogenesis and wound healing. Adv Healthc Mater. 2022; 11: e2002070.

[122] Wang Z, Feng C, Liu H, Meng T, Huang WQ, Song KX, et al. Exosomes from circ-Astn1-modified adipose-derived mesenchymal stem cells enhance wound healing through miR-138-5p/SIRT1/FOXO1 axis regulation. World J Stem Cells. 2023; 15: 476-89.

[123] Shi R, Jin Y, Hu W, Lian W, Cao C, Han S, et al. Exosomes derived from mmu_circ_0000250-modified adipose-derived mesenchymal stem cells promote wound healing in diabetic mice by inducing miR-128-3p/SIRT1-mediated autophagy. Am J Physiol Cell Physiol. 2020; 318: C848-56.

[124] Ge L, Wang K, Lin H, Tao E, Xia W, Wang F, et al. Engineered exosomes derived from miR-132-overexpresssing adipose stem cells promoted diabetic wound healing and skin reconstruction. Front Bioeng Biotechnol. 2023; 11: 1129538.

[125] Kojima R, Bojar D, Rizzi G, Hamri GC, El-Baba MD, Saxena P, et al. Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson’s disease treatment. Nat Commun. 2018; 9: 1305.

[126] Yu M, Liu W, Li J, Lu J, Lu H, Jia W, et al. Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway. Stem Cell Res Ther. 2020; 11: 350.

[127] Li Q, Guo L, Wang J, Tao S, Jin P. Exosomes derived from Nr-CWS pretreated MSCs facilitate diabetic wound healing by promoting angiogenesis via the circIARS1/miR-4782-5p/VEGFA axis. Chin J Nat Med. 2023; 21: 172-84.

[128] He X, Kuang G, Wu Y, Ou C. Emerging roles of exosomal miRNAs in diabetes mellitus. Clin Transl Med. 2021; 11: e468. https://doi.org/10.1002/ctm2.468.

[129] Gondaliya P, Sayyed AA, Bhat P, Mali M, Arya N, Khairnar A, et al. Mesenchymal stem cell-derived exosomes loaded with miR-155 inhibitor ameliorate diabetic wound healing. Mol Pharm. 2022; 19: 1294-308.

[130] Madhyastha R, Madhyastha H, Nakajima Y, Omura S, Maruyama M. MicroRNA signature in diabetic wound healing: promotive role of miR-21 in fibroblast migration. Int Wound J. 2012; 9: 355-61.

[131] Hade MD, Suire CN, Suo Z. An effective peptide-based platform for efficient Exosomal loading and cellular delivery of a microRNA. ACS Appl Mater Interfaces. 2023; 15: 3851-66.

[132] Chen WJ, Huang JW, Niu CC, Chen LH, Yuan LJ, Lai PL, et al. Use of fluorescence labeled mesenchymal stem cells in pluronic F127 and porous hydroxyapatite as a bone substitute for posterolateral spinal fusion. J Orthop Res. 2009; 27: 1631-6.

[133] Shiekh PA, Singh A, Kumar A. Exosome laden oxygen releasing antioxidant and antibacterial cryogel wound dressing OxOBand alleviate diabetic and infectious wound healing. Biomaterials. 2020; 249: 120020.

[134] Chen Y, Younis MR, He G, Zheng Z, Wang Y, Xue K, et al. Oxidative stimuli-responsive "pollen-like" exosomes from silver Nanoflowers Remodeling diabetic wound microenvironment for accelerating wound healing. Adv Healthc Mater. 2023; 12: e2300456.

[135] Zhang Y, Li M, Wang Y, Han F, Shen K, Luo L, et al. Exosome/metformin-loaded self-healing conductive hydrogel rescues microvascular dysfunction and promotes chronic diabetic wound healing by inhibiting mitochondrial fission. Bioact Mater. 2023; 26: 323-36.

[136] Hu YQ, Wu B, Xiong Y, Tao RY, Panayi AC, Chen L, et al. Cryogenic 3D printed hydrogel scaffolds loading exosomes accelerate diabetic wound healing. Chem Eng J. 2021; 426: 130634.

[137] Hu N, Cai Z, Jiang X, Wang C, Tang T, Xu T, et al. Hypoxia-pretreated ADSC-derived exosome-embedded hydrogels promote angiogenesis and accelerate diabetic wound healing. Acta Biomater. 2023; 157: 175-86.

[138] Sun B, Wu F, Wang X, Song Q, Ye Z, Mohammadniaei M, et al. An optimally designed engineering exosome-reductive COF integrated Nanoagent for synergistically enhanced diabetic fester wound healing. Small. 2022; 18: e2200895.

[139] Cai Y, Chen K, Liu C, Qu X. Harnessing strategies for enhancing diabetic wound healing from the perspective of spatial inflammation patterns. Bioact Mater. 2023; 28: 243-54.

[140] Khezri K, Maleki Dizaj S, Rahbar Saadat Y, Sharifi S, Shahi S, Ahmadian E, et al. Osteogenic differentiation of mesenchymal stem cells via curcumin-containing Nanoscaffolds. Stem Cells Int. 2021; 2021: 1520052-9.

[141] De Matteis V, Rizzello L, Ingrosso C, Liatsi-Douvitsa E, De Giorgi ML, De Matteis G, et al. Cultivar-dependent anticancer and antibacterial properties of silver nanoparticles synthesized using leaves of different Olea Europaea trees. Nanomaterials (Basel). 2019; 9. https://doi.org/10.3390/nano9111544.

[142] Kolanthai E, Fu Y, Kumar U, Babu B, Venkatesan AK, Liechty KW, et al. Nanoparticle mediated RNA delivery for wound healing. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022; 14: e1741.

[143] Jovic D, Liang X, Zeng H, Lin L, Xu F, Luo Y. Single-cell RNA sequencing technologies and applications: a brief overview. Clin Transl Med. 2022; 12: e694.

[144] Lotfy A, AboQuella NM, Wang H. Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials. Stem Cell Res Ther. 2023; 14: 66.

[145] Tang M, Chen Y, Li B, Sugimoto H, Yang S, Yang C, et al. Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis. FASEB J. 2021; 35: e21557.